Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:

Content type

Project (627)
Result in Brief (110)
Report Summary (91)


Australia (1)
Austria (41)
Belgium (97)
Bulgaria (2)
Cameroon (1)
Canada (2)
Czech Republic (2)
Denmark (85)
Finland (79)
France (299)
Germany (287)
Greece (43)
Hungary (2)
Iceland (1)
Ireland (25)
Israel (24)
Italy (234)
Netherlands (189)
Norway (25)
Poland (2)
Portugal (21)
Slovenia (2)
Spain (97)
Sweden (137)
Switzerland (59)
United Kingdom (376)

Advanced search

Search projects and results

Results 1 - 10 of 828
12 3 4 5 6 7 8 9 10 > >| 
ID: BMH4961658
Start date: 1996-08-01, End date: 1998-09-30
The scientific objectives include achievement of quantitative spectroscopy by developing an advanced European Near Infrared Spectroscopy instrument, designed to meet the requirements of the clinicians. and improve and validate image reconstruction algorithms and improve data a...
Programme: FP4-BIOMED 2
Record Number: 32511
Last updated on: 1997-10-10
The long term goal of this programme is to prevent the development of chronic complications in diabetic patients by implantation of an insulin producing beta cell graft. Our working hypothesis is that successful transplantation of beta cells requires grafts with selected size,...
Programme: FP4-BIOMED 2
Record Number: 8747
Last updated on: 1998-03-18
Using the genetic disease cystic fibrosis (CF) as a model, this project aimed to pursue a high quality of technical results and information concerning these results in the European laboratories involved. Further quality control trials of the laboratory tests and a permanent ed...
Programme: FP4-BIOMED 2
Record Number: 8748
Last updated on: 1996-10-24
ID: BMH4960462
Start date: 1996-05-01, End date: 2000-01-31
- To develop high quality procedures for genetic testing and counselling. This will be achieved by testing and training in laboratory methods providing quality supplies, and by developig sets of information documents and forms for the practioner and the patient. - To stimulat...
Programme: FP4-BIOMED 2
Record Number: 38504
Last updated on: 2001-12-07
ID: BMH4951561
Start date: 1996-01-01, End date: 1998-12-31
- To conduct a clinical trial on beta cell transplantation in diabetic patients with the purpose of identifying graft and recipient conditions which favour survival of beta cell allograft prepared from donor pancreata. - To develop alternative sources for beta cell grafts wit...
Programme: FP4-BIOMED 2
Record Number: 30907
Last updated on: 2001-12-07
ID: BMH4983549
Start date: 1998-04-01, End date: 2001-07-31
Objectives: 1. To evaluate the performance (capacity, robustness, precision etc.) of the novel tHcy assay in 4 different laboratories, located in 4 European countries, in comparison with HPLC tHcy determinations. 2. To apply the two assay variants for the measurement of tHcy i...
Programme: FP4-BIOMED 2
Record Number: 43539
Last updated on: 2002-11-18
ID: BMH4961444
Start date: 1996-04-01, End date: 1999-09-30
This Concerted Action, of three years duration, will examine developments and potential developments in reproductive medicine. It will offer a comparative analysis of legislation analysis of legislation currently in force in member states to examine how far such legislation is...
Programme: FP4-BIOMED 2
Record Number: 38566
Last updated on: 1999-12-21
A promising biotechnology method for diabetes
Diabetes mellitus refers to a group of diseases characterised by high blood glucose resulting from defects in insulin secretion, insulin action, or both. Especially, in non insulin-dependent diabetes mellitus (NIDDM), muscle is the key tissue for glucose clearance. This method...
Programme: FP4-BIOMED 2
Record Number: 80397
Last updated on: 2005-09-18
Available languages: DE, EN, ES, FR, IT
Prometedor método biotecnológico para la diabetes
La diabetes mellitus hace referencia a un grupo de enfermedades que se caracterizan por un nivel elevado de glucosa en sangre, como consecuencia de defectos en la secreción de insulina, la acción de la insulina, o ambas cosas. En especial, en la diabetes mellitus no dependient...
Programme: FP4-BIOMED 2
Record Number: 80397
Last updated on: 2005-09-18
Available languages: DE, EN, ES, FR, IT
Ein viel versprechendes biotechnologisches Verfahren zur Behandlung von Diabetes
Unter Diabetes mellitus versteht man eine Gruppe von Krankheiten, die durch einen hohen Glucosespiegel im Blut auf Grund von Fehlfunktionen der Insulinsekretion, der Insulinwirkung oder beider Mechanismen gekennzeichnet sind. Insbesondere beim nicht insulinabhängigen Diabetes ...
Programme: FP4-BIOMED 2
Record Number: 80397
Last updated on: 2005-09-18
Available languages: DE, EN, ES, FR, IT
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-12-13
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top